FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

40444811000001106: Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Feb 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1940361000001119 Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1940371000001112 Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose Has VMP Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler true Inferred relationship Existential restriction modifier
Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Seffalair Spiromax 12.75micrograms/dose / 100micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose Is a True Fluticasone propionate 100micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start